Prognostic value of lymphocyte count in severe COVID-19 patients with corticosteroid treatment
Main Authors: | Chenyang Lu, Yi Liu, Bo Chen, Hang Yang, Huifang Hu, Yi Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-03-01
|
Series: | Signal Transduction and Targeted Therapy |
Online Access: | https://doi.org/10.1038/s41392-021-00517-3 |
Similar Items
-
Dynamic changes of D-dimer and neutrophil-lymphocyte count ratio as prognostic biomarkers in COVID-19
by: Wenjing Ye, et al.
Published: (2020-07-01) -
A model to predict the risk of mortality in severely ill COVID-19 patients
by: Bo Chen, et al.
Published: (2021-01-01) -
The value of lymphocyte count in determining the severity of COVID-19 and estimating the time for nucleic acid test results to turn negative
by: Yuanchao Li, et al.
Published: (2020-09-01) -
Prognostic Value of Fibrinogen and Lymphocyte Count in Intermediate and High Risk Gastrointestinal Stromal Tumors
by: Guo Y, et al.
Published: (2020-09-01) -
Prognostic Value of Preoperative Absolute Lymphocyte Count in Children With Tetralogy of Fallot
by: Xie Wu, et al.
Published: (2021-06-01)